El Salvador has announced the selection of six sub-recipients (SR) for its $23.1 million HIV grant, marking another step forward on its path towards completing the Global Fund’s processes under the new funding model (NFM).
A UNAIDS special report released in November has warned of a risk that regional progress in Asia and the Pacific in stemming the spread of HIV is stagnating, recommending a closer look at value for money and strategic targets for external and domestic co-financing of prevention, treatment and care activities.
Côte d’Ivoire is known throughout West Africa as the most tolerant country, where gay, lesbian and transgender people from all backgrounds do not have to fear the same kind of systematic violence or opprobrium that plagues them elsewhere in the region.
Despite the Global Fund’s progressive policies on the inclusion of gay men, other men who have sex with men and transgender individuals (GMT) in programmes supported by the Fund, only a tiny fraction of the money spent by the Fund in six countries in Southern Africa has targeted this population.
Civil society organisations (CSOs) and advocates for key population endorse the basic thrust of the new funding model (NFM), but are concerned about several aspects, according to a new report from the International Council of AIDS Service Organisations (ICASO).
When is the Global Fund finally going to make it easier for Non-CCMs to apply to the Fund to address the needs of vulnerable populations that have been left out of the national response?
As mentioned in Article 1, Round 10 applicants from countries that have concentrated HIV/AIDS epidemics within "most-at-risk populations" (MARPs) have the option of applying for funding specifically for MARPs under a new funding stream.
The Global Fund is supporting programmes that address HIV-related human rights issues; however, countries do not appear to be using this opportunity to establish and scale up all of the programmes needed to reduce stigma and discrimination and increase access to justice in national responses to HIV.
The Global Fund Board yesterday concluded a two-day meeting in Kunming, China. This was the first board meeting chaired by Rajat Gupta, former CEO of McKinsey & Co., and the first attended by Michel Kazatchkine since he settled in as the new Executive Director.